2m 2m 2m 2m 2m 2m 2m
NUVECTIS PHARMA (NVCT)
NASDAQ
$9.24-$0.07 (-0.75%)
Price as of Jun 03, 2026 4:10 PM EDT- $258.6MMarket Cap
- 5.08%1-Year Change
- BiotechnologyIndustry
NUVECTIS PHARMA (NVCT)
$9.24-$0.07 (-0.75%)
NVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.31 | ||
Change | -$0.20 (-2.10%) | ||
Open | $9.50 | ||
High | $9.68 | ||
Low | $9.22 | ||
Previous Close | $9.51 | ||
Volume | 68,785 | ||
30-Day Average Volume | 123,759 | ||
1-Week Change | -8.28% | ||
1-Month Change | 9.02% | ||
1-Year Change | 5.08% | ||
3-Year Change | -47.04% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 26.5M | ||
Total Assets | $25.4M | ||
Market Cap | $258.6M | ||
Enterprise Value | $233.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.0M | ||
Free Cash Flow | -$6.5M | ||
EBIT | -$6.0M | ||
EBITDA | -$6.0M | ||
Net Working Capital | $14.2M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 18 | ||
P/E | -38 | ||
PEG | -2 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue